Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer.
Kosuke HamaiShinya MiyakaShinpei TadaSuguru FujitaTetsu HirakawaMirai MatsumuraSayaka UenoTakuya TanimotoNobuhisa IshikawaPublished in: Cancer reports (Hoboken, N.J.) (2023)
due to nonhematological toxicities.